Biocon CSR arm wins 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022 Ruchika Sharma25 Jan 2023 10:00 AM ISTBengaluru: Biocon Foundation, the Corporate Social Responsibility (CSR) arm of Biocon Limited, has been awarded the Gold Award in the ‘Diseases...
Biocon Chief Kiran Mazumdar Shaw leads investment in women's health platform Gytree Ruchika Sharma12 Jan 2023 1:38 PM ISTGytree will be directly available to consumers through the easy to use web-app, but also to corporations who prioritise female workforce and their...
Biocon Biologics gets complete response letter from USFDA for proposed biosimilar Insulin-R Ruchika Sharma9 Jan 2023 12:15 PM ISTBangalore: Biopharmaceutical company Biocon has announced that the US health regulator has issued a complete response letter for Biocon...
Dr S Eswara Reddy rejoins CDSCO as Joint drug controller Ruchika Sharma29 Dec 2022 1:00 PM ISTThe Delhi High Court in September had granted bail to Reddy who was then in judicial custody.
Biocon in collaboration with Equillium begins Itolizumab clinical study for Ulcerative Colitis in India Ruchika Sharma15 Dec 2022 5:00 PM ISTItolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6- ALCAM pathway, which can drive several...
Biocon Biologics appoints Shreehas Tambe as new MD, CEO Roshni Dhar6 Dec 2022 5:19 PM ISTBiocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been appointed as the...
Health Bulletin 6/December/2022 Roshni Dhar6 Dec 2022 4:35 PM ISTHere are the top health news for the day:Ceiling breakdown at Kalawati Saran Children's HospitalConcerns regarding the safety of patients and medical...
Biocon Biologics names Shreehas Tambe as new MD, CEO Ruchika Sharma5 Dec 2022 4:15 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been...
Viatris sells global biosimilars business to Biocon Biologics for USD 3 billion Ruchika Sharma30 Nov 2022 11:23 AM ISTThe acquisition provides Biocon Biologics with direct commercial capabilities and supporting infrastructure in the advanced markets and several...
Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital Ruchika Sharma25 Nov 2022 12:15 PM ISTThe funds raised from Ascent will be utilized towards undertaking strategic acquisitions, establishing a best-in-class R&D facility, and ramping up...
Biotechnology major Biocon net profit declines 11 percent to Rs 168 crore in Q2 Ruchika Sharma15 Nov 2022 2:30 PM ISTMazumdar-Shaw said the consolidation of Viatris' global biosimilars business and the strategic vaccines alliance with Serum Institute will add to the...
Biocon arm wins Asia IP Elite Award Ruchika Sharma12 Nov 2022 1:00 PM ISTA record 80 organisations around the Asia-Pacific region featured in this year's event, which was organized after a gap of two years.
